Co-Diagnostics, Inc. · LS:A41UNJ
Co-Diagnostics, Inc. shareholders
As of Sep 30, 2026, 23 institutions reported holding Co-Diagnostics, Inc., 2.8% of its shares. Largest: Vanguard, Geode Capital and Private Advisory Group LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Co-Diagnostics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 78,051 | 0.74% | no change | Nov 13, 2026 |
| Geode Capital | 49,599 | 0.47% | +24,024 | Nov 6, 2026 |
| Private Advisory Group LLC | 39,387 | 0.37% | no change | Nov 6, 2026 |
| Hrt Financial LP | 30,355 | 0.29% | new | Nov 13, 2026 |
| Citigroup Inc | 25,301 | 0.24% | new | Nov 4, 2026 |
| Jane Street | 24,086 | 0.23% | −65,154 | Nov 12, 2026 |
| Susquehanna | 15,986 | 0.15% | −15,253 | Nov 16, 2026 |
| State Street | 14,800 | 0.14% | no change | Nov 12, 2026 |
| Tower Research Capital LLC (TRC) | 7,684 | 0.07% | new | Nov 16, 2026 |
| JPMorgan | 1,993 | 0.02% | +1,990 | Nov 12, 2026 |